Structure Therapeutics, Inc. (GPCR)
67.78
+0.40
(+0.59%)
USD |
NASDAQ |
Dec 30, 16:00
67.80
+0.02
(+0.03%)
After-Hours: 20:00
Structure Therapeutics Enterprise Value: 3.112B for Dec. 30, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Eli Lilly & Co. | 999.05B |
| Novo Nordisk A/S | 238.40B |
| Pfizer Inc. | 189.11B |
| Viking Therapeutics, Inc. | 3.279B |
| Terns Pharmaceuticals, Inc. | 3.362B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -65.80M |
| Total Expenses (Quarterly) | 65.80M |
| EPS Diluted (Quarterly) | -1.125 |
| Earnings Yield | -5.39% |
| Normalized Earnings Yield | -5.389 |